nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—Olanzapine—H1F0—ocular cancer	0.0649	0.47	CrCbGaD
Loxapine—Quetiapine—H1F0—ocular cancer	0.0394	0.285	CrCbGaD
Loxapine—Clozapine—H1F0—ocular cancer	0.0339	0.245	CrCbGaD
Loxapine—CHRM5—Signaling Pathways—CDKN1A—ocular cancer	0.000146	0.000169	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—EP300—ocular cancer	0.000145	0.000168	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—CCND1—ocular cancer	0.000144	0.000167	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—TP53—ocular cancer	0.000144	0.000167	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—TP53—ocular cancer	0.000143	0.000165	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—AKT1—ocular cancer	0.000142	0.000165	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MDM2—ocular cancer	0.000142	0.000165	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—CCND1—ocular cancer	0.000142	0.000165	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MDM2—ocular cancer	0.000141	0.000164	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—CDKN1A—ocular cancer	0.000139	0.000161	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—EP300—ocular cancer	0.000139	0.000161	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—HRAS—ocular cancer	0.000138	0.00016	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MDM2—ocular cancer	0.000137	0.000159	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—CDKN1A—ocular cancer	0.000137	0.000159	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—HRAS—ocular cancer	0.000137	0.000159	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—HRAS—ocular cancer	0.000137	0.000159	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—HRAS—ocular cancer	0.000136	0.000158	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—AKT1—ocular cancer	0.000136	0.000158	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CDKN1B—ocular cancer	0.000136	0.000157	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—AKT1—ocular cancer	0.000135	0.000157	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MDM2—ocular cancer	0.000135	0.000157	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CDKN1B—ocular cancer	0.000134	0.000156	CbGpPWpGaD
Loxapine—ADRB1—GPCR downstream signaling—AKT1—ocular cancer	0.000134	0.000156	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—MYC—ocular cancer	0.000134	0.000156	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—MYC—ocular cancer	0.000134	0.000155	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—TGFB1—ocular cancer	0.000134	0.000155	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—AKT1—ocular cancer	0.000134	0.000155	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—TGFB1—ocular cancer	0.000134	0.000155	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—MYC—ocular cancer	0.000133	0.000154	CbGpPWpGaD
Loxapine—ADRA2B—GPCR downstream signaling—AKT1—ocular cancer	0.000133	0.000154	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—TGFB1—ocular cancer	0.000133	0.000154	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—EP300—ocular cancer	0.000132	0.000154	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—HRAS—ocular cancer	0.000132	0.000153	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—EP300—ocular cancer	0.000132	0.000153	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—HRAS—ocular cancer	0.000131	0.000152	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—EP300—ocular cancer	0.000131	0.000152	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—MYC—ocular cancer	0.00013	0.000151	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—TGFB1—ocular cancer	0.00013	0.000151	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CDKN1B—ocular cancer	0.00013	0.00015	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CCND1—ocular cancer	0.000129	0.00015	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CDKN1B—ocular cancer	0.000129	0.00015	CbGpPWpGaD
Loxapine—HTR1A—GPCR downstream signaling—AKT1—ocular cancer	0.000128	0.000149	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—MYC—ocular cancer	0.000128	0.000149	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CCND1—ocular cancer	0.000128	0.000149	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—TGFB1—ocular cancer	0.000128	0.000148	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—HRAS—ocular cancer	0.000128	0.000148	CbGpPWpGaD
Loxapine—HTR2C—GPCR downstream signaling—AKT1—ocular cancer	0.000128	0.000148	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—MYC—ocular cancer	0.000126	0.000147	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—TGFB1—ocular cancer	0.000126	0.000146	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—HRAS—ocular cancer	0.000126	0.000146	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CDKN1B—ocular cancer	0.000125	0.000146	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—CDKN1A—ocular cancer	0.000125	0.000145	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MDM2—ocular cancer	0.000125	0.000145	CbGpPWpGaD
Loxapine—ADRA2C—GPCR downstream signaling—AKT1—ocular cancer	0.000124	0.000144	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—CDKN1A—ocular cancer	0.000124	0.000144	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CCND1—ocular cancer	0.000124	0.000144	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CDKN1B—ocular cancer	0.000123	0.000143	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CCND1—ocular cancer	0.000123	0.000143	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MDM2—ocular cancer	0.000123	0.000142	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MDM2—ocular cancer	0.000122	0.000142	CbGpPWpGaD
Loxapine—ADRA1B—GPCR downstream signaling—AKT1—ocular cancer	0.000122	0.000142	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MDM2—ocular cancer	0.000122	0.000142	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—AKT1—ocular cancer	0.000122	0.000141	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MDM2—ocular cancer	0.000122	0.000141	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—AKT1—ocular cancer	0.000121	0.000141	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—MYC—ocular cancer	0.000121	0.00014	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—TGFB1—ocular cancer	0.000121	0.00014	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—AKT1—ocular cancer	0.000121	0.00014	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MDM2—ocular cancer	0.00012	0.00014	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—AKT1—ocular cancer	0.00012	0.00014	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MDM2—ocular cancer	0.00012	0.000139	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CCND1—ocular cancer	0.00012	0.000139	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—CDKN1A—ocular cancer	0.00012	0.000139	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—CDKN1A—ocular cancer	0.000119	0.000138	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—EP300—ocular cancer	0.000119	0.000138	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—EP300—ocular cancer	0.000118	0.000137	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CCND1—ocular cancer	0.000118	0.000137	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—EP300—ocular cancer	0.000117	0.000135	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—AKT1—ocular cancer	0.000116	0.000135	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—AKT1—ocular cancer	0.000116	0.000134	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—HRAS—ocular cancer	0.000116	0.000134	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—CDKN1A—ocular cancer	0.000116	0.000134	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—MYC—ocular cancer	0.000115	0.000134	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—TGFB1—ocular cancer	0.000115	0.000134	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—HRAS—ocular cancer	0.000114	0.000132	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—CDKN1A—ocular cancer	0.000114	0.000132	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—EP300—ocular cancer	0.000114	0.000132	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—MYC—ocular cancer	0.000114	0.000132	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CDKN1B—ocular cancer	0.000114	0.000132	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—HRAS—ocular cancer	0.000114	0.000132	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—TGFB1—ocular cancer	0.000114	0.000132	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—HRAS—ocular cancer	0.000113	0.000132	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—EP300—ocular cancer	0.000113	0.000131	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—HRAS—ocular cancer	0.000113	0.000131	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—AKT1—ocular cancer	0.000113	0.000131	CbGpPWpGaD
Loxapine—DRD2—GPCR downstream signaling—AKT1—ocular cancer	0.000113	0.000131	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CDKN1B—ocular cancer	0.000112	0.00013	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—HRAS—ocular cancer	0.000112	0.00013	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CDKN1B—ocular cancer	0.000112	0.00013	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MDM2—ocular cancer	0.000112	0.000129	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—HRAS—ocular cancer	0.000112	0.000129	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CDKN1B—ocular cancer	0.000111	0.000129	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CDKN1B—ocular cancer	0.000111	0.000129	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—AKT1—ocular cancer	0.000111	0.000129	CbGpPWpGaD
Loxapine—HTR2A—GPCR downstream signaling—AKT1—ocular cancer	0.000111	0.000129	CbGpPWpGaD
Loxapine—HRH1—GPCR downstream signaling—AKT1—ocular cancer	0.000111	0.000128	CbGpPWpGaD
Loxapine—CHRM1—GPCR downstream signaling—AKT1—ocular cancer	0.00011	0.000128	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—EP300—ocular cancer	0.00011	0.000128	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—TP53—ocular cancer	0.00011	0.000128	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CDKN1B—ocular cancer	0.00011	0.000128	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—TP53—ocular cancer	0.00011	0.000128	CbGpPWpGaD
Loxapine—CHRM3—GPCR downstream signaling—AKT1—ocular cancer	0.00011	0.000127	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CDKN1B—ocular cancer	0.00011	0.000127	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—TP53—ocular cancer	0.000109	0.000127	CbGpPWpGaD
Loxapine—CHRM2—GPCR downstream signaling—AKT1—ocular cancer	0.000109	0.000126	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CCND1—ocular cancer	0.000109	0.000126	CbGpPWpGaD
Loxapine—ADRA1A—GPCR downstream signaling—AKT1—ocular cancer	0.000108	0.000126	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—EP300—ocular cancer	0.000108	0.000126	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—EP300—ocular cancer	0.000107	0.000124	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—TP53—ocular cancer	0.000107	0.000124	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CCND1—ocular cancer	0.000107	0.000124	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CCND1—ocular cancer	0.000107	0.000124	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CCND1—ocular cancer	0.000106	0.000123	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CCND1—ocular cancer	0.000106	0.000123	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—HRAS—ocular cancer	0.000105	0.000122	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—TP53—ocular cancer	0.000105	0.000122	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—HRAS—ocular cancer	0.000105	0.000122	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—CDKN1A—ocular cancer	0.000105	0.000122	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CCND1—ocular cancer	0.000105	0.000122	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CCND1—ocular cancer	0.000105	0.000121	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—HRAS—ocular cancer	0.000104	0.000121	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—TP53—ocular cancer	0.000104	0.00012	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—MYC—ocular cancer	0.000104	0.00012	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—HRAS—ocular cancer	0.000104	0.00012	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TGFB1—ocular cancer	0.000103	0.00012	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—CDKN1A—ocular cancer	0.000103	0.00012	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—CDKN1A—ocular cancer	0.000103	0.00012	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—CDKN1A—ocular cancer	0.000103	0.000119	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—MYC—ocular cancer	0.000103	0.000119	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TGFB1—ocular cancer	0.000103	0.000119	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—CDKN1A—ocular cancer	0.000102	0.000119	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—HRAS—ocular cancer	0.000102	0.000119	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—AKT1—ocular cancer	0.000102	0.000119	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CDKN1B—ocular cancer	0.000102	0.000118	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—CDKN1A—ocular cancer	0.000101	0.000118	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—CDKN1A—ocular cancer	0.000101	0.000117	CbGpPWpGaD
Loxapine—ADRA2A—GPCR downstream signaling—AKT1—ocular cancer	0.000101	0.000117	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—HRAS—ocular cancer	0.000101	0.000117	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—AKT1—ocular cancer	0.000101	0.000117	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—AKT1—ocular cancer	0.0001	0.000116	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—AKT1—ocular cancer	0.0001	0.000116	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—EP300—ocular cancer	0.0001	0.000116	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—AKT1—ocular cancer	9.98e-05	0.000116	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—TP53—ocular cancer	9.94e-05	0.000115	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—HRAS—ocular cancer	9.93e-05	0.000115	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—MYC—ocular cancer	9.92e-05	0.000115	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TGFB1—ocular cancer	9.9e-05	0.000115	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—AKT1—ocular cancer	9.88e-05	0.000115	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—MYC—ocular cancer	9.87e-05	0.000115	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—AKT1—ocular cancer	9.85e-05	0.000114	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TGFB1—ocular cancer	9.85e-05	0.000114	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—EP300—ocular cancer	9.84e-05	0.000114	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—EP300—ocular cancer	9.81e-05	0.000114	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—EP300—ocular cancer	9.78e-05	0.000114	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—EP300—ocular cancer	9.75e-05	0.000113	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CCND1—ocular cancer	9.72e-05	0.000113	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—EP300—ocular cancer	9.66e-05	0.000112	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—EP300—ocular cancer	9.63e-05	0.000112	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—MYC—ocular cancer	9.6e-05	0.000111	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TGFB1—ocular cancer	9.58e-05	0.000111	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—HRAS—ocular cancer	9.51e-05	0.00011	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—TP53—ocular cancer	9.47e-05	0.00011	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—MYC—ocular cancer	9.45e-05	0.00011	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TGFB1—ocular cancer	9.42e-05	0.000109	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—CDKN1A—ocular cancer	9.4e-05	0.000109	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—TP53—ocular cancer	9.35e-05	0.000108	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—AKT1—ocular cancer	9.29e-05	0.000108	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—AKT1—ocular cancer	9.28e-05	0.000108	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—AKT1—ocular cancer	9.22e-05	0.000107	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—AKT1—ocular cancer	9.15e-05	0.000106	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—HRAS—ocular cancer	9.06e-05	0.000105	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—AKT1—ocular cancer	9.03e-05	0.000105	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—EP300—ocular cancer	8.95e-05	0.000104	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—HRAS—ocular cancer	8.94e-05	0.000104	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—AKT1—ocular cancer	8.89e-05	0.000103	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—AKT1—ocular cancer	8.77e-05	0.000102	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—MYC—ocular cancer	8.71e-05	0.000101	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TGFB1—ocular cancer	8.69e-05	0.000101	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—MYC—ocular cancer	8.57e-05	9.94e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—MYC—ocular cancer	8.55e-05	9.92e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TGFB1—ocular cancer	8.55e-05	9.92e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TGFB1—ocular cancer	8.53e-05	9.9e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—MYC—ocular cancer	8.52e-05	9.89e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—TP53—ocular cancer	8.52e-05	9.88e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TGFB1—ocular cancer	8.5e-05	9.87e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—MYC—ocular cancer	8.5e-05	9.86e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TGFB1—ocular cancer	8.48e-05	9.84e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—TP53—ocular cancer	8.44e-05	9.79e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—MYC—ocular cancer	8.41e-05	9.76e-05	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—AKT1—ocular cancer	8.4e-05	9.74e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TGFB1—ocular cancer	8.39e-05	9.74e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—MYC—ocular cancer	8.39e-05	9.74e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TGFB1—ocular cancer	8.37e-05	9.71e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—TP53—ocular cancer	8.15e-05	9.45e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—HRAS—ocular cancer	8.15e-05	9.45e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—TP53—ocular cancer	8.11e-05	9.4e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—HRAS—ocular cancer	8.07e-05	9.37e-05	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—AKT1—ocular cancer	8e-05	9.28e-05	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—AKT1—ocular cancer	7.96e-05	9.24e-05	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—AKT1—ocular cancer	7.89e-05	9.16e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—TP53—ocular cancer	7.88e-05	9.15e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—MYC—ocular cancer	7.8e-05	9.05e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—HRAS—ocular cancer	7.79e-05	9.04e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TGFB1—ocular cancer	7.78e-05	9.03e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TP53—ocular cancer	7.76e-05	9e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—HRAS—ocular cancer	7.75e-05	8.99e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—HRAS—ocular cancer	7.54e-05	8.75e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—HRAS—ocular cancer	7.42e-05	8.61e-05	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—AKT1—ocular cancer	7.19e-05	8.35e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TP53—ocular cancer	7.15e-05	8.3e-05	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—AKT1—ocular cancer	7.13e-05	8.27e-05	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—AKT1—ocular cancer	7.05e-05	8.18e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TP53—ocular cancer	7.04e-05	8.17e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TP53—ocular cancer	7.02e-05	8.15e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TP53—ocular cancer	7e-05	8.12e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TP53—ocular cancer	6.98e-05	8.1e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TP53—ocular cancer	6.91e-05	8.02e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TP53—ocular cancer	6.89e-05	8e-05	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—AKT1—ocular cancer	6.88e-05	7.98e-05	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—AKT1—ocular cancer	6.84e-05	7.94e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—HRAS—ocular cancer	6.84e-05	7.94e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—HRAS—ocular cancer	6.73e-05	7.81e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—HRAS—ocular cancer	6.72e-05	7.79e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—HRAS—ocular cancer	6.7e-05	7.77e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—HRAS—ocular cancer	6.67e-05	7.74e-05	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—AKT1—ocular cancer	6.66e-05	7.72e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—HRAS—ocular cancer	6.61e-05	7.67e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—HRAS—ocular cancer	6.59e-05	7.65e-05	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—AKT1—ocular cancer	6.55e-05	7.6e-05	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—AKT1—ocular cancer	6.47e-05	7.5e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TP53—ocular cancer	6.4e-05	7.43e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—HRAS—ocular cancer	6.12e-05	7.11e-05	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—AKT1—ocular cancer	6.04e-05	7.01e-05	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—AKT1—ocular cancer	5.94e-05	6.9e-05	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—AKT1—ocular cancer	5.93e-05	6.88e-05	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—AKT1—ocular cancer	5.91e-05	6.86e-05	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—AKT1—ocular cancer	5.89e-05	6.84e-05	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—AKT1—ocular cancer	5.84e-05	6.77e-05	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—AKT1—ocular cancer	5.82e-05	6.75e-05	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—AKT1—ocular cancer	5.41e-05	6.27e-05	CbGpPWpGaD
